Bank of America
TAK icon

Bank of America’s Takeda Pharmaceutical TAK Stock Holding History

Bank of America’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.93M Sell
307,312
-12,657
-4% -$209K ﹤0.01% 3577
2026
Q1 		$5.93M Sell
319,969
-42,899
-12% -$753K ﹤0.01% 3334
2025
Q4 		$5.66M Sell
362,868
-5,482
-1% -$78.4K ﹤0.01% 3290
2025
Q3 		$5.39M Sell
368,350
-668,813
-64% -$9.93M ﹤0.01% 3922
2025
Q2 		$16M Buy
1,037,163
+718,805
+226% +$10.6M ﹤0.01% 2782
2025
Q1 		$4.73M Sell
318,358
-44,159
-12% -$619K ﹤0.01% 3853
2024
Q4 		$4.8M Sell
362,517
-533,765
-60% -$7.33M ﹤0.01% 3630
2024
Q3 		$12.7M Buy
896,282
+29,223
+3% +$415K ﹤0.01% 2846
2024
Q2 		$11.2M Sell
867,059
-616,950
-42% -$8.17M ﹤0.01% 2839
2024
Q1 		$20.6M Buy
1,484,009
+649,696
+78% +$9.45M ﹤0.01% 2255
2023
Q4 		$11.9M Sell
834,313
-1,365,965
-62% -$19.4M ﹤0.01% 2691
2023
Q3 		$34M Buy
2,200,278
+1,354,853
+160% +$21M ﹤0.01% 1551
2023
Q2 		$13.3M Sell
845,425
-451,412
-35% -$7.4M ﹤0.01% 2428
2023
Q1 		$21.4M Buy
1,296,837
+440,000
+51% +$7.01M ﹤0.01% 2060
2022
Q4 		$13.4M Sell
856,837
-252,419
-23% -$3.53M ﹤0.01% 2396
2022
Q3 		$14.4M Buy
1,109,256
+262,641
+31% +$3.65M ﹤0.01% 2240
2022
Q2 		$11.9M Sell
846,615
-2,541,293
-75% -$36.3M ﹤0.01% 2514
2022
Q1 		$48.5M Buy
3,387,908
+231,268
+7% +$3.4M ﹤0.01% 1382
2021
Q4 		$43M Sell
3,156,640
-910,856
-22% -$12.8M ﹤0.01% 1515
2021
Q3 		$66.6M Buy
4,067,496
+1,916,142
+89% +$32.2M 0.01% 1181
2021
Q2 		$36.2M Sell
2,151,354
-510,290
-19% -$8.69M ﹤0.01% 1607
2021
Q1 		$48.6M Buy
2,661,644
+731,126
+38% +$13.2M 0.01% 1315
2020
Q4 		$35.1M Sell
1,930,518
-1,268,439
-40% -$22.3M ﹤0.01% 1426
2020
Q3 		$57.1M Buy
3,198,957
+100,994
+3% +$1.84M 0.01% 1014
2020
Q2 		$55.5M Buy
3,097,963
+33,459
+1% +$601K 0.01% 973
2020
Q1 		$46.5M Sell
3,064,504
-894,748
-23% -$16.2M 0.01% 995
2019
Q4 		$78.1M Sell
3,959,252
-87,627
-2% -$1.68M 0.01% 911
2019
Q3 		$69.6M Buy
4,046,879
+304,513
+8% +$5.27M 0.01% 935
2019
Q2 		$66.2M Buy
3,742,366
+1,340,772
+56% +$24.4M 0.01% 945
2019
Q1 		$48.9M Sell
2,401,594
-4,496,879
-65% -$90.5M 0.01% 1125
2018
Q4 		$116M Buy
+6,898,473
New +$116M 0.02% 614

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Bank of America's TAK Position: Q2 2026 in Review

Bank of America reduced its Takeda Pharmaceutical (TAK) stake by 4% in Q2 2026, selling an estimated $209K and leaving 307,312 shares worth $4.93M. The position accounts for ﹤0.01% of the portfolio, ranked #3577.

Bank of America first reported a position in TAK in Q4 2018 and has held it in 31 quarters since. The position peaked at $116M in Q4 2018. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Bank of America held 307,312 shares of Takeda Pharmaceutical worth $4.93M as of Q2 2026.
  • Bank of America sold 12,657 Takeda Pharmaceutical shares in Q2 2026, an estimated $209K.
  • Takeda Pharmaceutical made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #3577 holding.
  • Bank of America first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 31 quarters since.
  • Bank of America's Takeda Pharmaceutical position peaked at $116M in Q4 2018.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.